Options
Barreto, George
Loading...

Nombre preferido
Barreto, George
Nombre oficial
George Emilio Barreto
Afiliación principal
96 results
Now showing 1 - 10 of 96
- PublicationChitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects(Wiley-Liss Inc., 2019)
;Saheb M. ;Fereydouni N. ;Nemati S.; ;Johnston T.P.Sahebkar A. - PublicationNew therapeutic property of dimebon as a neuroprotective agent(Bentham Science Publishers B.V., 2018)
;Ustyugov A. ;Shevtsova E.; ;Ashraf G.M. ;Bachurin S.O.Aliev G. - PublicationA review of the pharmacological and therapeutic effects of auraptene(Blackwell Publishing Inc., 2019)
;Bibak B. ;Shakeri F.; ;Keshavarzi Z. ;Sathyapalan T.Sahebkar A. - PublicationLipid-based nanoformulations in the treatment of neurological disorders(Taylor and Francis Ltd, 2020)
;Pottoo F.H. ;Sharma S. ;Javed M.N. ;Barkat M.A. ;Harshita ;Alam M.S. ;Naim M.J. ;Alam O. ;Ansari M.A.; Ashraf G.M. - PublicationMolecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease(Springer, 2020)
;Uddin M.S. ;Tewari D. ;Sharma G. ;Kabir M.T.; ;Bin-Jumah M.N. ;Perveen A. ;Abdel-Daim M.M.Ashraf G.M. - PublicationTibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression(Elsevier Ireland Ltd, 2016)
;Avila-Rodriguez M. ;Garcia-Segura L.M. ;Hidalgo-lanussa O. ;Baez E. ;Gonzalez J. - PublicationTargeting the nicotinic acetylcholine receptors (nAChRs) in astrocytes as a potential therapeutic target in Parkinson’s disease(Bentham Science Publishers, 2016)
;Jurado-Coronel J.C. ;Ávila-Rodriguez M. ;Capani F. ;Gonzalez J. ;Morán V.E.